Home / Investors / Startups / Neurelis

Neurelis

Neurelis is a specialty pharmaceutical company providing a highly differentiated approach to target unmet medical needs.

About Neurelis

Neurelis is a specialty pharmaceutical company, licenses, develops, and commercializes product candidates for epilepsy and the broader central nervous system (CNS) market. It provides a differentiated approach to target unmet medical needs. Their application of novel technologies is designed to enhance the therapeutic benefit and patient care. The company was incorporated in 2007 and is based in Encinitas, California.

Industries

Investors in Neurelis (4)